spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Domain Associates 

 HSMN NewsFeed - 16 Sep 2020
Signifier Medical Technologies Closes $10M Series C Funding Round
Devices Venture Capital
 HSMN NewsFeed - 19 May 2020
ChromaCode Raises $10 Million Series C Financing From Adjuvant Capital
Diagnostics Venture Capital
 HSMN NewsFeed - 1 Apr 2020
Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 9 Jan 2020
Omniome Closes $60 Million Series C Financing To Advance Novel Genomic Sequencing Platform
Diagnostics Venture Capital
 HSMN NewsFeed - 17 Dec 2019
ChromaCode Raises $28 Million in Series C Financing
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 12 Dec 2019
Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 20 Nov 2019
Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 3 Jan 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2018
Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Devices Dermatology FDA
 HSMN NewsFeed - 21 Jun 2018
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
Diagnostics OB/GYN Personnel
 HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Devices Endocrinology Venture Capital
 HSMN NewsFeed - 1 Aug 2017
Milestone Pharmaceuticals Closes $55 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 19 May 2017
Iterum Secures $65 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel
 HSMN NewsFeed - 28 Apr 2017
Epic Sciences Announces Completion of $40 Million Series D Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 10 Jan 2017
Adynxx Announces Closing of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Nov 2016
ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop(R) Near Vision Inlay
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 12 Sep 2016
Obalon Announces FDA Approval of Obalon Balloon System
Devices Gastroenterology FDA
 HSMN NewsFeed - 6 Sep 2016
ROX Medical Raises $40M Financing
Devices Interventional Venture Capital
 HSMN NewsFeed - 10 Jun 2016
Merck to Acquire Afferent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Nov 2015
Fractyl Announces Completion of $57 Million Series C Investment
Devices Endocrinology Venture Capital
 HSMN NewsFeed - 14 Oct 2015
Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 3 Mar 2015
Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases
Devices Oncology Regulatory
 HSMN NewsFeed - 24 Feb 2015
Shire Acquires Meritage Pharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Feb 2015
Xagenic Hires Vice President of Product Development to Expand Molecular Diagnostic Offerings and Speed Pipeline-to-Market
Diagnostics Personnel
 HSMN NewsFeed - 22 Oct 2014
aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2014
Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 30 Jun 2014
Benvenue Medical Expands Senior Management Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 18 Jun 2014
Benvenue Medical Secures $64 Million Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2014
Miramar Labs Secures $10 Million in Series D Funding
Devices Venture Capital
 HSMN NewsFeed - 11 Feb 2014
Mallinckrodt plc to Acquire Cadence Pharmaceuticals, Inc. for $14.00 Per Share, in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Lithera Announces Final Closing of $35.6 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Feb 2014
aTyr Pharma Appoints Frederic Chereau as President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2014
Kiva(R) VCF Treatment System Receives FDA Clearance For Vertebral Compression Fractures
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 4 Sep 2013
Otonomy Completes $45.9 Million Series C Equity Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Aug 2013
Syndax Pharmaceuticals Secures $26.6 Million Series B Financing for Advancement of Epigenetic Therapies for Treatment-Resistant Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 20 Aug 2013
Applied Proteomics Inc. Completes $28 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 1 Aug 2013
Dicerna Secures $60 Million in Oversubscribed Series C Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 29 Jul 2013
ReVision Optics Closes $55 Million Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 23 May 2013
Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris
Devices Cardiology
 HSMN NewsFeed - 15 Apr 2013
Carticept(R) Medical Receives 510(k) Clearance for Second Generation Navigator(R) Delivery System
Devices Drug Delivery FDA
 HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 4 Apr 2013
New Therapy for Wet AMD Introduced in Switzerland by Oraya(R) Therapeutics and EyeRAD
Devices Ophthalmology
 HSMN NewsFeed - 25 Feb 2013
Cubist Announces Exclusive Option to Acquire Adynxx
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Feb 2013
Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 7 Jan 2013
RusnanoMedInvest and Domain Associates Invest In Neurology Company Marinus Pharmaceuticals
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 4 Dec 2012
Kona Medical Closes $40 Million Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 13 Nov 2012
Epic Sciences Announces Series B Financing to Advance Essential Cancer Diagnostics for Personalized Medicine
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 31 Jul 2012
Benvenue Medical Completes Enrollment in KAST Study Evaluating Kiva(R) vs. Kyphoplasty
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 28 Jun 2012
Benvenue Medical Secures $25 Million Series D Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 7 Jun 2012
Astute Medical Completes $40.4 Million Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 30 May 2012
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 3 May 2012
Oraya Therapeutics Achieves Successful INTREPID Study Outcomes with a Non-Invasive Radiation Therapy for Wet AMD
Devices Ophthalmology
 HSMN NewsFeed - 5 Apr 2012
Syndax Pharmaceuticals Appoints Arthur M. Pappas to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Apr 2012
Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director
Diagnostics Personnel
 HSMN NewsFeed - 20 Mar 2012
Benvenue Medical Starts Enrolling Patients in the Post-Market LIFT Study on the Luna Interbody Spacer System for Degenerative Disc Disease
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 20 Jan 2012
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Diagnostics Endocrinology Oncology Personalized Medicine
 HSMN NewsFeed - 18 Jan 2012
Carticept Medical(TM) Closes $10 Million Series C Financing Round
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 20 Jul 2011
Carticept Medical(TM) Receives 510(k) Clearance for Navigator(TM) Delivery System
Devices Drug Delivery FDA
 HSMN NewsFeed - 19 Apr 2011
Durata Therapeutics Initiates Phase 3 Study of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2011
CoDa Therapeutics Closes $19 Million Series B Financing Round
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 18 Apr 2011
Benvenue Medical Closes $35.5 Million Series C Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 20 Dec 2010
NovaDigm Therapeutics Appoints C. Boyd Clarke to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2010
Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 26 Oct 2010
aTyr Pharma Secures $23M Financing From Top Tier Venture Investor
Biopharmaceuticals Venture Captial
 HSMN NewsFeed - 21 Oct 2010
Dicerna Pharmaceuticals Announces Second Close of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory
 HSMN NewsFeed - 13 Oct 2010
Cell Biosciences to Acquire Convergent Bioscience
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 29 Sep 2010
Tobira Therapeutics Inc. Raises $31 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Sep 2010
Eddingpharm (Cayman) Inc. Announces Closing of Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology
 HSMN NewsFeed - 1 Sep 2010
GI Dynamics Announces Distribution Agreement with Elemental Healthcare for the EndoBarrier Gastrointestinal Liner
Devices Distribution
 HSMN NewsFeed - 1 Sep 2010
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Aug 2010
GI Dynamics Announces Key Executive Appointments in Preparation for European Launch of EndoBarrier Gastrointestinal Liner
Devices Gastroenterology Personnel
 HSMN NewsFeed - 11 Aug 2010
Dicerna Closes $25 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Jul 2010
Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 9 Jun 2010
Veracyte Completes $28 Million Series B Round - One Step Closer to Commercializing First Molecular Diagnostic Product
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 2 Jun 2010
Apnex Medical, Inc. Names Chas McKhann President, Chief Executive Officer
Devices Neurology Personnel
 HSMN NewsFeed - 13 May 2010
Sequent Medical Announces Closing of $15.6 Million Venture Financing
Devices Interventional Venture Capital Personnel
 HSMN NewsFeed - 13 May 2010
Nuon Therapeutics Names Lee Rauch Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2010
Oraya Therapeutics Granted European CE Mark for the IRay(TM) Stereotactic Radiotherapy System
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 7 Apr 2010
Achaogen Completes $56 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Mar 2010
Proteostasis Therapeutics Announces Additions of Key Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Jan 2010
The Foundry Announces Completion of Series A Financing for Twelfth Company
Devices Venture Capital
 HSMN NewsFeed - 12 Jan 2010
VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jan 2010
GI Dynamics Receives Strategic Investment from Medtronic, Inc.
Devices Gastroenterology Venture Capital
 HSMN NewsFeed - 5 Jan 2010
Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD
Devices Ophthalmology
 HSMN NewsFeed - 22 Dec 2009
GI Dynamics Receives European CE Mark Approval for the EndoBarrier Gastrointestinal Liner System for the Treatment of Type 2 Diabetes and Obesity
Devices Gastroenterology Regulatory
 HSMN NewsFeed - 21 Dec 2009
Newly Formed Durata Therapeutics Acquires Pfizer's Vicuron Subsidiary
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 17 Dec 2009
Regado Biosciences, Inc. Completes $40 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 7 Dec 2009
Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche
Biopharmaceuticals Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 3 Dec 2009
Apnex Medical, Inc. Raises Additional $14 Million
Devices Venture Capital
 HSMN NewsFeed - 11 Nov 2009
Altair Therapeutics Secures $17 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jul 2009
Marinus Pharmaceuticals Adds Two Life Sciences Veterans to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2009
Oraya Therapeutics Raises $42 Million in Series C Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 16 Jul 2009
Nuon Therapeutics Appoints Paulette Dillon, Chief Business Officer, and Tito Serafini, Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2009
Clovis Oncology Raises $145 Million in Start-Up Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 10 Apr 2009
Marinus Pharmaceuticals Raises $20 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Feb 2009
GI Dynamics Closes an Additional $15 Million in Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 13 Oct 2008
Miramar Labs Names Zoromski As CEO
Devices Dermatology Personnel
 HSMN NewsFeed - 6 Oct 2008
Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
Devices
 HSMN NewsFeed - 29 Sep 2008
Oceana Therapeutics Commences Operations after Completing Series A Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2008
GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier(TM) Gastrointestinal Liner for Pre-Surgical Weight Loss
Devices
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2008
Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2008
Cortria Corporation Announces Appointment of Daniel Grau as CEO & Vice-Chairman and Richard King as Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Jun 2008
Tobira Therapeutics Inc. Announces Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2008
Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 May 2008
Carticept Medical Reports First Patients Treated in Pivotal Study of Agilus(TM) Therapy for Pain Associated with Ankle Osteoarthritis
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 1 May 2008
Esperion Therapeutics Completes $22.75 M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Apr 2008
Nuon Therapeutics Inc. Completes $27 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Apr 2008
TargetRx Completes $9.6M Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Feb 2008
M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2008
Ocera Therapeutics Closes $35.5 Million Series C Financing
Biopharmaceuticals Gastroenterology Venture Capital
 HSMN NewsFeed - 7 Feb 2008
BioVascular Inc. Closes $10.87 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Jan 2008
Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 Dec 2007
Corthera Closes $23 Million Financing Round
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Nov 2007
Novalar Raises $30 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Oct 2007
Optherion, Inc. Completes $37 Million Start Up Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 5 Oct 2007
Helixis, Inc. Announces Advanced Technology Ventures' Role in Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 27 Sep 2007
Sequel Pharmaceuticals Raises $20 Million in Series A Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 19 Sep 2007
Allergan, Inc. Announces Agreement to Acquire Esprit Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2007
Carticept Medical Expands Management Team with Appointment of Chris Fair to Vice President, Sales and Marketing
Devices Orthopaedic Personnel
 HSMN NewsFeed - 2 Aug 2007
Celator Closes $10 Million Follow-On Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Aug 2007
Tobira Therapeutics Inc. Completes $31 Million Series A Financing and Names Management Team
Biopharmaceuticals HIV/AIDS Venture Capital Personnel
 HSMN NewsFeed - 25 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2007
APNEX Medical, Inc. Raises $16.1 Million in Series 'A' Financing
Devices Venture Capital
 HSMN NewsFeed - 30 Apr 2007
ReVision Optics, Inc. Raises $25M in Series D Financing
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 26 Apr 2007
Northstar Neuroscience Announces Management and Board Succession Plan
Devices Neurology Personnel
 HSMN NewsFeed - 16 Apr 2007
Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2007
Ascenta Therapeutics Raises $50 Million in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Apr 2007
Syndax Pharmaceuticals Inc. Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Mar 2007
Milestone Scientific Signs Agreement With Carticept Medical to Collaborate on CompuFlo(TM) Injection System for Treatment of Arthritic Joints
Devices Drug Delivery
 HSMN NewsFeed - 14 Mar 2007
Tragara Pharmaceuticals, Inc. Announces Corporate Launch and Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Mar 2007
VentiRx Pharmaceuticals Announces $28.9 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Nov 2006
Alimera Sciences Completes Second Tranche of Series B Financing, Receives $15.9 Million
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 25 Oct 2006
CoLucid Names James F. White as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Sep 2006
NovaCardia Raises $48 Million in Series B
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 10 Jul 2006
Ocera Therapeutics, Inc. Raises $12 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 May 2006
Ocera Therapeutics Initiates Phase 3 Trial in Fistulizing Crohn's Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 19 May 2006
Esprit Pharma Acquires Exclusive North American Rights to a Novel Treatment for Hypoactive Sexual Desire Disorder in Women from Novavax
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 May 2006
Esprit Pharma Appoints Vice President of Trade
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
Domain Associates
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!